Product Name :
LIR-6 (F83) Peptide Applications :
Blocking Background :
LILRA3 is a member of leukocyte immunoglobulin-like receptor gene family. Leukocyte Ig-like receptors (LIRs) are a family of inhibitory and stimulatory immunoreceptors expressed predominantly on monocytes and B cells and at lower levels on dendritic cells and natural killer (NK) cells. LILRA3 lacks a transmembrane region and may act as a soluble receptor for class I MHC antigens. It is expressed in B-cells, and at lower levels in natural killer (NK) cells. Alternative Name :
LILRA1; CD85I; LIR-6; LIR6; MGC126563; leucocyte immunoglobulin-like receptor-6b (lir-6); leucocyte immunoglobulin-like receptors-6b (lir-6) Swiss-Prot :
O75019 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide LIR-6 (F83). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS3138 LIR-6 (F83) pAb.

• 

Blocking peptide available as BS3138PP